Download to read offline
Uploaded byPraveen Nagula
QUIZ ON HF - ROUND 4 - how much do you bet.pptx
Each team will be given list of topics in heart failure - they can choose any topic - they have to answer atleast 3 out of 5 questions pertaining to the topic - they have to bet before answering the questions - 1:2.1:3,1:4 - then 800,1200,1600 for each question - if they win bet based on questions answered they will get ex: 1:2 then each question is 800 points, then for 3 questions, 4 questions, 5 questions answered they will get 2400,3200,4000 if they lose bet half of points will be lost - 2000.
More Related Content
Similar to QUIZ ON HF - ROUND 4 - how much do you bet.pptx
![Heart failure – an update [autosaved]](https://cdn.slidesharecdn.com/ss_thumbnails/heartfailureanupdateautosaved-110321012825-phpapp02-thumbnail.jpg?width=640&height=640&fit=bounds)
More from Praveen Nagula
QUIZ ON HF - ROUND 4 - how much do you bet.pptx
- 1. HOME ROUND 4 How muchdo you bet?
- 2. PHARMACOTHERAPY CHRONIC HEARTFAILURE SURGICAL MANAGEMENT CARDIOMYOPATHIES VALVULAR HEART DISEASE HEART TRANSPLANTATION PERCUTANEOUS DEVICES ADVANCES IN HF HF TRIALS ACUTE HEART FAILURE
- 3.
- 4. Question 1 • Whichis the most potent loop diuretic?
- 5. Question 2 • Whichaquaretic is non-selective and can be given IV only?
- 6. Question 3 • Whatis the CV mortality benefit of beta-blockers in HFrEF?
- 7. Question 4 • Whichbiomarker appropriately defines HF when patient is on ARNI?
- 8. Question 5 • 2/3rd ofpatients with heart failure have PAH. Newer drug for PAH which acts by rebalancing the activin signalling pathway?
- 9.
- 10. Question 1 •What isthe trial of DAPAGLIFLOZIN in HFPEF?
- 11. Question 2 • However,it was not clear if beta-blockers (BBs) had the same beneficial effects in patients with HF who experience severe HF symptoms and have a significantly low quality of life. One trial has shown the benefit of BBs in this subset of HF. What is the trial?
- 12. Question 3 • Whatare the subjects of PIONEER HF?
- 13. Question 4 • Whatare the trials of Vericiguat in Heart Failure?
- 14. Question 5 • ARTEMIStrial is related to which drug?
- 15.
- 16. Question 1 • Whatis Dor Surgery?
- 17. Question 2 • Whatis the mortality of CABG + DVR?
- 18. Question 3 • Whatis the graft patency rate at one year after CABG?
- 19. Question 4 • Whatis Dry tamponade?
- 20. Question 5 • Whatis the modified maze procedure?
- 21.
- 22. Question 1 • Whatis the name of this ball and cage valve?
- 23. Question 2 • Whatis the drawback of STS score?
- 24. Question 3 • Whatis the basis for the development of MitraClip?
- 25. Question 4 • ElKhoury’s system classification is for which VHD?
- 26. Question 5 • Whatis the cut-off of the LV dimensions for surgical management of severe MR?
- 27.
- 28. Question 1 • Whohas done the first heterotopic heart transplantation?
- 29. Question 2 • Exercisecapacity under ... metabolic equivalents is equal to VO2 <14ml/kg/min. It is a stronger predictor of death in patients with HF after MI.
- 30. Question 3 • Whichscore is used in assessing PVO2 with moderate accuracy as measured by the cardiopulmonary testing?
- 31. Question 4 • Whatis the difference between cardiac allograft vasculopathy compared to CAD? Tell any two differences.
- 32. Question 5 • Mostcommon complication with the use of calcineurin inhibitors post TRx is?
- 33.
- 34. Question 1 • Whatis the volume of a “mega” intra-aortic balloon?
- 35. Question 2 • Namethe device.
- 36. Question 3 • Theratio of central venous pressure to pulmonary capillary wedge pressure, which predicts RV failure, is?
- 37. Question 4 • Namethe durable LVAD
- 38. Question 5 • HARLEQUINsyndrome?
- 39.
- 40. Question 1 • Whichtrial showed that there will be a 39% increase in the hazard ratio for mortality for every 10% reduction in LVEF?
- 41. Question 2 • Normalvalue of tau, the rate of relaxation?
- 42. Question 3 • Targetserum levels of digoxin in patients with HF who are advised to take digoxin
- 43. Question 4 • Whichof the three isoforms of NOS mediated vasodilation is blunted in heart failure?
- 44. Question 5 • Onceconsidered as transcriptional noise, now emerged as a potential biomarkers as well as a therapeutic target in HF. Name any one marker?
- 45.
- 46. Question 1 • WhichIV inotrope does not cause an increase in myocardial oxygen demand?
- 47. Question 2 • INTERMACSstand for
- 48. Question 3 • Whichacute heart failure registry has been done globally?
- 49. Question 4 • Whatis hemodynamic congestion ?
- 50. Question5 • Which trialshowed that the start of ARNI in hospital is ideal rather than outpatient setting?
- 51.
- 52. Question 1 • Whatare the five attributes of MOGES classification?
- 53. Question 2 • Whichcardiomyopathy is the paradigmatic example of how similar phenotypes may be caused by different genes and mutations.
- 54. Question 3 • DCMPwith conduction system disease has which gene affected?
- 55. Question 4 • Whichdeficiency is related to the cause of PPCM ?
- 56. Question 5 • Describethe Brockenbrough Braun Wald Morrow phenomenon?
- 57. SCORES TEAM SCORE The HeartyWalkers Aorta’s Avengers Guardians of the Heart Cardiac Cruisers